Delivery Order SPE2DR25D1104-SPE2DR26FK714
- Not listed
- The Defense Logistics Agency awarded a $3,649.00 delivery order contract to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL quantity) with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes with a ceiling value of $5,473.50 under a firm fixed price arrangement. The award was made on August 7, 2025, with an ultimate completion date of August 28, 2025. This non-competitive delivery order represents a small-value pharmaceutical supply transaction, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $9,122.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on September 12, 2025, with completion targeted for October 3, 2025. This non-competitive delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $18,245 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a completion date of July 11, 2025. This non-set-aside, firm fixed price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's extensive federal pharmaceutical distribution portfolio and is issued under the company's larger...
- The Defense Logistics Agency awarded a $7,298.00 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price contract, with an ultimate completion date of September 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. The contract was...
- The Defense Logistics Agency awarded a $15,382 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Gel-One 30 mg/3 mL syringes (3 mL). This firm fixed-price, competitively awarded contract is scheduled for completion by December 26, 2025, with performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 23, 2025, with completion targeted for October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $15,382.00 and a completion date of December 30, 2025. This competitive award, issued under a firm fixed-price structure, represents a child delivery order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,298.00 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Gel-One 30 mg/3 mL syringes (3 mL quantity). The contract carries a firm fixed price structure with no set-aside designation and an ultimate completion date of October 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $3,649.00 delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on September 9, 2025, with completion targeted for September 30, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed-price arrangement for pharmaceutical supply delivery to support federal medical procurement needs. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK714Delivery Order
The Defense Logistics Agency awarded a $7,691 firm fixed price delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on December 18, 2025, with completion targeted for January 12, 2026. This non-competitive delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a broad range of medical products to federal customers, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex medical procurement requirements across multiple therapeutic domains. The Gel-One delivery order supports the Defense Health Agency's medical supply chain by providing this ophthalmic viscosurgical device, commonly used in cataract surgery and other anterior segment eye procedures, contributing to the broader mission of supplying essential medical commodities to military and veteran healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 12/17/25 |